Morgan Stanley lowered the firm’s price target on Accelerant (ARX) to $18 from $26 and keeps an Equal Weight rating on the shares. The firm said that, broadly speaking, commercial property and casualty continues to face growth headwinds from the commercial property pricing slowdown in both primary and reinsurance sub-sectors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX:
- Accelerant price target lowered to $18 from $25 at Piper Sandler
- Accelerant upgraded to Buy from Neutral at Goldman Sachs
- Mixed Sentiment on Accelerant Holdings: Hold Rating Amid Growth and Structural Challenges
- Accelerant price target lowered to $21 from $33 at Raymond James
- Accelerant partners with AF Specialty to boost risk exchange capacity